| 000 | 01852 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515014638.0 | ||
| 264 | 0 | _c20060608 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a0161-3499 | ||
| 024 | 7 |
_a10.1111/j.1532-950X.2006.00122.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchmiedt, Chad | |
| 245 | 0 | 0 |
_aUse of capecitabine after renal allograft transplantation in dog erythrocyte antigen-matched dogs. _h[electronic resource] |
| 260 |
_bVeterinary surgery : VS _cFeb 2006 |
||
| 300 |
_a113-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Chemical Analysis _xveterinary |
| 650 | 0 | 4 | _aCapecitabine |
| 650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
| 650 | 0 | 4 |
_aDeoxycytidine _xadverse effects |
| 650 | 0 | 4 |
_aDogs _xsurgery |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDose-Response Relationship, Immunologic |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xanalogs & derivatives |
| 650 | 0 | 4 |
_aGraft Rejection _xveterinary |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aKetoconazole _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 |
_aNephrectomy _xveterinary |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aPrednisolone _xtherapeutic use |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTransplantation Immunology |
| 650 | 0 | 4 |
_aTransplantation, Homologous _xveterinary |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPenzo, Chiara | |
| 700 | 1 | _aSchwab, Michelle | |
| 700 | 1 | _aDubielzig, Richard | |
| 700 | 1 | _aMcAnulty, Jonathan | |
| 773 | 0 |
_tVeterinary surgery : VS _gvol. 35 _gno. 2 _gp. 113-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1532-950X.2006.00122.x _zAvailable from publisher's website |
| 999 |
_c16084838 _d16084838 |
||